Loading...
XJPX
4202
Market cap2.22bUSD
Dec 05, Last price  
1,298.50JPY
1D
-1.18%
1Q
-6.92%
Jan 2017
0.66%
Name

Daicel Corp

Chart & Performance

D1W1MN
XJPX:4202 chart
P/E
6.97
P/S
0.59
EPS
186.37
Div Yield, %
4.00%
Shrs. gr., 5y
-3.23%
Rev. gr., 5y
7.28%
Revenues
586.53b
+5.10%
335,520,000,000381,422,000,000416,989,000,000377,979,000,000320,243,000,000353,684,000,000341,942,000,000358,513,000,000413,786,000,000443,775,000,000449,878,000,000440,061,000,000462,956,000,000464,859,000,000412,826,000,000393,568,000,000467,937,000,000538,026,000,000558,056,000,000586,531,000,000
Net income
49.48b
-11.38%
14,220,000,00017,438,000,00013,675,000,0001,296,000,00011,069,000,00016,802,000,00011,827,000,00015,372,000,00022,843,000,00031,252,000,00040,313,000,00043,198,000,00037,062,000,00035,301,000,0004,978,000,00019,713,000,00031,254,000,00040,682,000,00055,834,000,00049,481,000,000
CFO
93.41b
+21.73%
32,780,000,00025,534,000,00049,275,000,00040,165,000,00066,445,000,00053,428,000,00034,000,000,00044,480,000,00044,777,000,00057,412,000,00065,419,000,00086,168,000,00066,888,000,00058,523,000,00057,193,000,00057,869,000,00042,993,000,00026,847,000,00076,729,000,00093,406,000,000
Dividend
Mar 30, 202630 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Daicel Corporation engages in the medical/healthcare, smart, safety, materials, engineering plastics, and other businesses in Japan, China, and internationally. The company offers 1,3-Butylene glycol and polyglycerin for cosmetics; chiral and achiral columns/stationary phases, analytical tools, analytical/purification/synthesis/formulation services, chiral and bio reagents, analytical standards, and DNA and RNA-based probes; triacetylcellulose, high performance film, solvent for electronic materials, polymer for resist, semiconductor process cleaning agent, optical parts and lens unit, silver nanoparticle ink, and organic semiconductor devices; and inflators, pyro-fuse, and safety device for non-mobility products; and acetic acid and derivatives, cellulose acetate, acetate tow, cycloaliphatic epoxies, caprolactone, ketene derivatives, and alkylamines. It also provides ceramide derived from konjac root, equol derived from soybeans, ß-cryptoxanthin derived from citrus unshiu, and lactobionic acid derived from milk; DiSPERZiSTA, a dispersible filler for dietary supplement tablet; and MOiSTCARM, a make granules easy to swallow. In addition, the company offers engineering plastics and plastic compound products, high performance polymer, functional sheets, formed trays, and packaging films; water treatment systems and diffusers, such as UF membrane modules, ultra-fine bubble membrane diffusers, and E mizu showers. Its products are used in transportation, electronics, medical care, personal care, everyday life, and environment and energy applications. The company was formerly known as Daicel Chemical Industries, Ltd. and changed its name to Daicel Corporation in October 2011. Daicel Corporation was incorporated in 1919 and headquartered in Osaka, Japan.
IPO date
May 16, 1949
Employees
11,207
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT